AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Sexually Transmitted Diseases Diagnostics Market Size, Trends, Analysis, and Outlook By Disease (CT/NG, Gonorrhea, HIV/AIDS, Genital Herpes, Hepatitis B, Syphilis, Mycoplasma Genitalium, Genital Warts, Candidal Vaginitis, Trichomoniasis, Bacterial Vaginosis, HPV, Others), By Test (Culture/Isolation Of Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)), by Country, Segment, and Companies, 2024-2032
... Organisms, Molecular Test, Immunology Assay, Others), By Device (Laboratory Devices, Point Of Care (Poc) Devices), By End-User (Laboratory, Point of Care (POC)), by Country, Segment, and Companies, 2024-2032 The global Sexually Transmitted Diseases Diagnostics market ... Read More
-
Serological Testing Market Size, Trends, Analysis, and Outlook By Technology (ELISA, NAT, CLIA/CMIA, Others), By Product (Instruments, Consumables and Reagents), By Application (Hepatitis, Coronavirus, Human Immunodeficiency Virus, Rotavirus infections, Others), By End-User (Diagnostic Laboratories, Hospitals, Others), by Country, Segment, and Companies, 2024-2032
... Others), by Country, Segment, and Companies, 2024-2032 The global Serological Testing market size is poised to register 8.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Global Syphilis Ab Rapid Test Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... that causes syphilis in a patient's blood sample. This test is used for the rapid screening and diagnosis of syphilis infection. According to our (Global Info Research) latest study, the global Syphilis Ab Rapid Test ... Read More
-
Herpes Simplex Virus Treatment Market Report by Type (Herpes Simples Virus-1 Infection, Herpes Simplex Virus-2 Infection, and Others), Drug Type (Acyclovir, Valacyclovir, Famciclovir, and Others), Route of Administration (Oral, Injectable, Topical), Distribution Channel (Hospital Pharmacy, Drug Stores, Retail Stores, Online Pharmacy), and Region 2024-2032
... Drug Stores, Retail Stores, Online Pharmacy), and Region 2024-2032 The global herpes simplex virus treatment market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion ... Read More
-
Cancer Cachexia Market Report by Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others), Mode of Action (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel (Hospital Stores, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
... market size reached US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.1% during 2024-2032. Cancer cachexia refers to ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2024-2032
... Home Care), and Region 2024-2032 The global women's health diagnostics market size reached US$ 29.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 52.6 Billion by 2032, exhibiting a growth ... Read More
-
Genital Herpes - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024
... the AIDS Related Kaposi's Sarcoma market. A detailed picture of the AIDS Related Kaposi's Sarcoma pipeline landscape is provided, which includes the disease overview and AIDS Related Kaposi's Sarcoma treatment guidelines. The assessment part of ... Read More
-
Syphilis - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Syphilis treatment guidelines. The assessment part of the report embraces in-depth Syphilis commercial assessment and clinical assessment of the Syphilis pipeline products from the pre-clinical ... Read More
-
Acquired Immunodeficiency Syndrome (AIDS) - Pipeline Insight, 2024
... the Acquired Immunodeficiency Syndrome (AIDS) market. A detailed picture of the Acquired Immunodeficiency Syndrome (AIDS) pipeline landscape is provided, which includes the disease overview and Acquired Immunodeficiency Syndrome (AIDS) treatment guidelines. The assessment part of ... Read More
-
Global Sexually Transmitted Diseases (STD) Testing Market -2024-2031
... of YY% during the forecast period 2024-2031. A sexually transmitted disease is a serious condition that can develop after having sex. Common STD symptoms include itching and burning around the genital area. Tests for sexually ... Read More
-
Self-Testing Market, by Product Type (Kits (Self-testing kits, Self-collection kits) Self-testing Devices), by Application Type (Blood Glucose Testing, Pregnancy Testing, Pulmonary Function Testing, Urinary Tract Infection Testing, Sexually transmitted infections (STIs) Testing, Genetic Testing, Vitamin and Mineral Deficiency Testing, COVID Testing, Allergy Testing, Gastrointestinal Screening, Hormone Testing, Food Sensitivity Testing, Others (Infectious Disease Testing, etc.)), by Sample Type (Blood, Saliva, Nasal, Stool, Urine and Others (Vaginal Swab Sample and Breathe Sample)), by Test Type (Laboratory Tests, Point of Care Tests/Homecare Tests), by Distribution Channel (Offline (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Supermarkets and Hypermarket) and Online), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031
... and Mineral Deficiency Testing, COVID Testing, Allergy Testing, Gastrointestinal Screening, Hormone Testing, Food Sensitivity Testing, Others (Infectious Disease Testing, etc.)), by Sample Type (Blood, Saliva, Nasal, Stool, Urine and Others (Vaginal Swab Sample and Breathe ... Read More
-
Global Genital Herpes Treatment Drugs Market Growth (Status and Outlook) 2024-2030
... growing demand in downstream market, the Genital Herpes Treatment Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Syphilis Testing Market Size, Trends, Analysis, and Outlook By Type (Primary & Secondary Syphilis, Others), By Location of Testing (Laboratory testing, Point of care (POC) testing), by Region, Country, Segment, and Companies, 2024-2030
... Syphilis Testing market size is poised to register 5.88% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Syphilis Testing market By ... Read More
-
Sexually Transmitted Disease Testing Market Size, Trends, Analysis, and Outlook By Disease (Chlamydia, Gonorrhea, Herpes simplex virus, Syphilis, Human papillomavirus (HPV), Others), By Testing (Laboratory testing, Point of care (POC) testing), by Region, Country, Segment, and Companies, 2024-2030
... and Companies, 2024-2030 The global Sexually Transmitted Disease Testing market size is poised to register 7.08% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Sexually Transmitted Diseases Treatment Market Size, Trends, Analysis, and Outlook By Disease (Gonorrhea, Syphilis, Herpes, Chlamydia, Hepatitis (HBV), Human Immunodeficiency Virus (HIV), Others), By Therapy (Anti-bacterial, Anti-viral, Vaccines, Anti-fungal), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Sexually Transmitted Diseases Treatment market size is poised to register 4.09% growth (CAGR) from 2024 to ... Read More
-
Point of Care HIV Testing Market Size, Trends, Analysis, and Outlook By Product (POC HIV testing equipment, POC HIV testing reagents), By End-User (Diagnostic labs, Hospitals and clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... 2024-2030 The global Point of Care HIV Testing market size is poised to register 3.98% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes ... Read More
-
Infectious Disease Diagnostics Market Assessment, By Product [Reagents, Kits, and Consumables, Instruments, Software], By Sample Type [Blood and Components, Urine, Other], By Setting [Laboratory Testing, Point-of-Care Testing], By Type of Testing [Molecular Tests, Serological Tests, Antigen Tests, Culture Tests, Blood Tests, Imaging Tests], By Indication [Bacterial Infections, Viral Infections, CNS Infections, Cardiovascular Infections, Fungal Infections, GI Infections, Sexually Transmitted Diseases, Other], By End-user [Diagnostic Laboratories, Academic And Medical Institutes, Hospitals, Ambulatory Clinics, Home Healthcare, Other], By Region, Opportunities and Forecast, 2017-2031F
... Antigen Tests, Culture Tests, Blood Tests, Imaging Tests], By Indication [Bacterial Infections, Viral Infections, CNS Infections, Cardiovascular Infections, Fungal Infections, GI Infections, Sexually Transmitted Diseases, Other], By End-user [Diagnostic Laboratories, Academic And Medical Institutes, Hospitals, ... Read More
-
Genital Herpes Market Assessment, By Type [Diagnosis, Treatment], By Route of Administration [Oral, Injectable, Topical], By End-user [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others], By Region, Opportunities and Forecast, 2017-2031F
... projected to witness a CAGR of 5.24% during the forecast period, 2024-2031, growing from USD 2.25 billion in 2023 to USD 3.39 billion in 2031. The global genital herpes market is shaped by various factors. ... Read More
-
Chile In Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... The emergence of COVID-19 has led to the health crisis that the world has witnessed and had an unprecedented impact on various industries and specifically the healthcare and biotechnology industries, including the in-vitro diagnostic market. ... Read More
-
Global Syphilis Testing Market - 2024-2031
... period 2024-2031 Syphilis is a highly contagious sexually transmitted disease primarily spread through sexual activity (oral or anal sex). It is caused by the bacteria Treponema pallidum. It is asymptomatic most of the time and ... Read More
-
Gonorrhea Diagnostic Market Size, Trends, Analysis, and Outlook By Type (Molecular Diagnostics Tests, Flow Cytometry, Diagnostic Imaging, Liposomes, Artificial Intelligence, Gel Micro-droplets, Chromatography, Differential Light Scattering, Monoclonal Antibodies), by Region, Country, Segment, and Companies, 2024-2030
... The global Gonorrhea Diagnostic market size is poised to register 8.1% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Gonorrhea Diagnostic market ... Read More
-
Herpes Simplex Virus Treatment Market Size, Trends, Analysis, and Outlook By Type (Herpes Simplex Virus-1 (HSV-1), Herpes simplex virus-2 (HSV-2), By Drug (Acyclovir, Valacyclovir, Famciclovir, Others), By Vaccine, Simplirix, Others), By Route of Administration (Oral, Injectable, Topical), By End-User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Injectable, Topical), By End-User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Herpes Simplex Virus Treatment market size is poised to register 8.63% growth from 2024 to 2030, ... Read More
-
Infectious Disease In Vitro Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Instruments, Reagents, Software Services), By Technology (Immunoassay, Molecular Diagnostics, Microbiology), By Application (MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, Respiratory Virus, Candida, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others), By Test Location (Point of Care, Central Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030
... and Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19, Others), By Test Location (Point of Care, Central Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Infectious ... Read More
-
Cryptococcosis Therapeutics Market Size, Trends, Analysis, and Outlook By Treatment (Amphotericin B , Flucytosine , Fluconazole , Others), By Diagnosis (Bronchoscopy, X-ray, MRI, Lung Biopsy, CSF Polymerase Chain Reaction (PCR), CT scan, Others), By End-User (Clinic, Hospital, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... (Clinic, Hospital, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Cryptococcosis Therapeutics market size is poised to register 4.8% growth from 2024 to 2030, ... Read More
Research Assistance
